Researcher
Peter Sinnaeve
- Disciplines:Cardiac and vascular medicine
Affiliations
- Cardiology (Division)
Member
From27 Sep 2004 → Today
Projects
1 - 9 of 9
- Safely ruling out ACS in patients with chest pain presenting to ambulatory careFrom19 May 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Patient preferences in cardiology: methodological aspects and integration decision-makingFrom6 Sep 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Effectiveness and cost-effectiveness of a personalised digital prevention network for high-cardiovascular-risk patients.From16 Nov 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The impact of hospital context on quality improvement for STEMI patientsFrom1 May 2014 → 22 Jan 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- Regulation of the transcriptome by circulating microRNAs in patients with acute coronary syndromes.From1 Sep 2013 → 29 May 2019Funding: FWO fellowships
- The role of microRNAs in the regulation of inflammation and oxidative stress in monocytes during obesity and associated metabolic disorders.From1 Oct 2012 → 30 Sep 2015Funding: FWO fellowships
- Cellular Interactions and Heterogeneity in Ischemic Cardiovascular DiseaseFrom1 Nov 2010 → 31 Oct 2018Funding: BOF - Concerted Research Project from 1994
- Light-based imaging of the coronary arteries: identification of vulnerable plaque and assessment of vessel wall healing.From1 Jan 2009 → 31 Dec 2013Funding: FWO research project (including WEAVE projects)
- Vascular biology.From1 Jan 2009 → 31 Dec 2015Funding: FWO scientific research network
Publications
21 - 30 of 223
- Antithrombotic treatment after surgical and transcatheter heart valve repair and replacement(2021)
Authors: Marie-Christine Herregods, Peter Verbrugghe, Marie Lamberigts, Thomas Vanassche, Bart Meyns, Wouter Oosterlinck, Filip Rega, Tom Adriaenssens, Lucas Van Hoof, Christophe Vandenbriele, et al.
- Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol(2021)
Authors: Peter Sinnaeve
Pages: 421 - 433 - Heart team 2.0: A decision tree for minimally invasive and hybrid myocardial revascularization(2021)
Authors: Johan Bennett, Tom Adriaenssens, Walter Desmet, Christophe Dubois, Peter Sinnaeve, Tom Verbelen, Steven Jacobs, Wouter Oosterlinck
Pages: 382 - 391 - Clec4e-Receptor Signaling in Myocardial Repair After Ischemia-Reperfusion Injury(2021)
Authors: Denise Veltman, Peter Pokreisz, Piet Claus, Willy Gsell, Uwe Himmelreich, Peter Sinnaeve
Pages: 631 - 646 - Two-year outcomes after percutaneous coronary intervention with drug-eluting stents or bare-metal stents in elderly patients with coronary artery disease(2021)
Authors: Peter Sinnaeve, Kris Bogaerts
Pages: E607 - E613 - COmplex Bifurcation Lesions: RAndomized Comparison of Modified-T Stenting vs Reconstruction With Self-Expanding Stent and Bioresorbable Scaffold: COBRA II(2021)
Authors: Johan Bennett, Tom Adriaenssens, Peter Sinnaeve, Walter Desmet, Christophe Dubois
Pages: E281 - + - Peripheral Blood RNAs and Left Ventricular Dysfunction after Myocardial Infarction: Towards Translation into Clinical Practice(2021)
Authors: Denise Veltman, Peter Sinnaeve
Pages: 213 - 221 - Dual Antiplatelet Therapy De-escalation Strategies(2021)
Authors: Peter Sinnaeve, Tom Adriaenssens
Pages: S23 - S31 - Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention Insights From the AUGUSTUS Trial(2021)
Authors: Peter Sinnaeve
Pages: 1215 - 1223 - AMPKα1 deletion in myofibroblasts exacerbates post-myocardial infarction fibrosis by a connexin 43 mechanism(2021)
Authors: Stephane Heymans, Peter Sinnaeve
Patents
1 - 3 of 3